This webinar will be hosted available and live on-demandThursday, September 28, 2023 9:30 AM Eastern Time Molecular research advances broaden the sensitivity and uniqueness of cancer detection, tracking, and characterization. In the past 2 researchers, clinicians and decades transformed precision medication to establish safer and more reliable cancer treatments based on the unique hereditary and molecular makeup of each tumor. In this webinar brought to you by Bio-Rad, Genevieve Boland and Francesca Orzan will present their latest research study using technical breakthroughs and molecular analyses to move unique assays more detailed to the clinic.Topics to be covered Plasma biomarkers for metastatic melanomaCerebrospinal fluid liquid biopsies for glioma medical diagnosis Genevieve Boland, MD, PhD Vice Chair of Research, Department of Surgery Section Head, Melanoma/Sarcoma Surgery Surgical Director, Termeer Center for Targeted Therapies Director, Surgical Oncology Research Laboratories MGH Research Scholar Massachusetts General Hospital Associate Professor of Surgery, Harvard Medical School Francesca Orzan, PhD Research Assistant Laboratory of Cancer Stem Cell Research Candiolo Cancer Institute – FPO, IRCCS Department of Oncology University of Torino Medical SchoolSponsored by
